immunogenicity


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to immunogenicity: humoral immunity

im·mu·no·gen·ic

 (ĭm′yə-nō-jĕn′ĭk, ĭ-myo͞o′-)
adj.
Capable of inducing an immune response.

im′mu·no·ge·nic′i·ty (-jə-nĭs′ĭtē)

immunogenicity

(ˌɪmjʊnəʊdʒɪˈnɪsɪtɪ)
n
the state of being immunogenic
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.immunogenicity - the property of eliciting an immune response
immunity, resistance - (medicine) the condition in which an organism can resist disease
References in periodicals archive ?
Although these SS DNA vaccines are superior over than conventional SS vaccines, the immunogenicity is still weak, and the effect of their growth-promoting of animals is not evident, especially in large animals.
DREAMM-1 is a first-in-human and open-label study of GSK2857916 designed to evaluate the safety, pharmacokinetics, pharmacodynamics, immunogenicity and clinical activity of the antibody drug conjugate GSK2857916 in patients with relapsed/refractory multiple myeloma and other advanced hematologic malignancies expressing B-cell maturation antigen.
From 2008 until 2013 she was Head of the In Vitro Immunogenicity group at AlgoNomics (Ghent, Belgium) and Lonza Applied Protein Services (Cambridge, UK).
26 ZEBOV and MVA-BN-Filo have already been administered to 122 healthy adults in Kericho County and its environs.The randomised, observer-blind, placebo-controlled, phase 2 study was done to evaluate the safety, tolerability and immunogenicity of the two prime- vaccines.
Cunningham, M.D., from the University of Sydney, and colleagues presented immunogenicity results from two trials involving patients aged 50 years or older and aged 70 years or older who received two doses of HZ/su or placebo two months apart.
From February 2016 to January 2018, the ACIP Hepatitis Vaccines Work Group ([dagger]) participated in three teleconference meetings to review the quality of evidence for immunogenicity and safety of HepB-CpG and implementation issues.
Immunogenicity is now known to be one of the main causes of this loss of response.
(3) Immunogenicity of 2 doses of the 9-valent HPV vaccine in girls and boys ages 9 to 14 was compared with that of a standard 3-dose regimen in adolescents and young women ages 16 to 26.
In this Phase III, open-label study, we assessed the immunogenicity and safety of Southern Hemisphere inactivated quadrivalent influenza vaccine (Fluarix[TM] Tetra) in Brazilian adults (NCT02369341).
The mechanisms for the development of response failure are complex; however, immunogenicity of these protein-based TNF antagonists has been recognized as a major factor (5).